We are live on ! Find out more
SBH

Segall Bryant & Hamill Portfolio holdings

AUM $8.43B
1-Year Est. Return 52.02%
This Fund
S&P 500
This Quarter Est. Return
+25.07%
1 Year Est. Return
+52.02%
3 Year Est. Return
+115.13%
5 Year Est. Return
+140.59%
10 Year Est. Return
+558.15%
AUM
$8.43B
AUM Growth
+$1.45B
Cap. Flow
+$163M
Cap. Flow %
1.93%
Top 10 Hldgs %
12.93%
Holding
678
New
102
Increased
209
Reduced
234
Closed
88

Top Buys

Rank Stock Value
1
TKR icon
Timken Company
TKR
+$45.3M
2
MARA icon
Marathon Digital Holdings
MARA
+$34.5M
3
LLY icon
Eli Lilly
LLY
+$29M
4
AVT icon
Avnet
AVT
+$26.8M
5
IEX icon
IDEX
IEX
+$25.6M

Sector Composition

Rank Sector Weight
1 Technology 22.85%
2 Industrials 21.43%
3 Financials 13.12%
4 Healthcare 12.2%
5 Consumer Discretionary 9.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRPT icon
326
Sarepta Therapeutics
SRPT
$2.38B
$4.64M 0.06%
+258,154
New +$4.88M
VLY icon
327
Valley National Bancorp
VLY
$7.75B
$4.64M 0.06%
316,483
-26,481
-8% -$360K
KNSA icon
328
Kiniksa Pharmaceuticals
KNSA
$6.08B
$4.6M 0.05%
+71,901
New +$3.73M
CI icon
329
Cigna
CI
$74.7B
$4.59M 0.05%
+16,639
New +$4.7M
QLYS icon
330
Qualys
QLYS
$5.94B
$4.52M 0.05%
32,904
-1,897
-5% -$187K
AUPH icon
331
Aurinia Pharmaceuticals
AUPH
$2.14B
$4.48M 0.05%
263,743
+117,464
+80% +$1.88M
KMT icon
332
Kennametal
KMT
$2.36B
$4.46M 0.05%
127,329
-14,068
-10% -$512K
HG icon
333
Hamilton Insurance Group
HG
$3.51B
$4.44M 0.05%
130,816
-15,108
-10% -$474K
DCH
334
Dauch Corp
DCH
$1.66B
$4.33M 0.05%
799,694
+652,759
+444% +$3.97M
AVY icon
335
Avery Dennison
AVY
$13.3B
$4.3M 0.05%
26,462
-1,303
-5% -$212K
SWK icon
336
Stanley Black & Decker
SWK
$14.7B
$4.29M 0.05%
45,627
+30,406
+200% +$2.38M
MANH icon
337
Manhattan Associates
MANH
$12.5B
$4.28M 0.05%
30,769
-16,804
-35% -$2.32M
PLOW icon
338
Douglas Dynamics
PLOW
$976M
$4.2M 0.05%
77,827
-6,645
-8% -$306K
REZI icon
339
Resideo Technologies
REZI
$3.02B
$4.19M 0.05%
134,737
-19,419
-13% -$668K
CMCO icon
340
Columbus McKinnon
CMCO
$544M
$4.18M 0.05%
276,238
-444,076
-62% -$6.61M
AMRX icon
341
Amneal Pharmaceuticals
AMRX
$6.07B
$4.16M 0.05%
240,060
-37,742
-14% -$517K
TPC
342
Tutor Perini Cor
TPC
$4.64B
$4.14M 0.05%
+49,877
New +$4.01M
LQDA icon
343
Liquidia Corp
LQDA
$6.15B
$4.05M 0.05%
50,802
-5,136
-9% -$275K
HRTG icon
344
Heritage Insurance Holdings
HRTG
$1.01B
$4M 0.05%
153,247
-11,985
-7% -$299K
NTCT icon
345
NETSCOUT
NTCT
$2.71B
$3.99M 0.05%
91,609
-7,234
-7% -$272K
SMG icon
346
ScottsMiracle-Gro
SMG
$3.46B
$3.93M 0.05%
57,656
+2,772
+5% +$172K
AVA icon
347
Avista
AVA
$3.14B
$3.89M 0.05%
95,120
-42,096
-31% -$1.73M
JXN icon
348
Jackson Financial
JXN
$9.52B
$3.83M 0.05%
37,447
-20,305
-35% -$2.2M
BA icon
349
Boeing
BA
$168B
$3.76M 0.04%
+17,365
New +$3.86M
O icon
350
Realty Income
O
$58B
$3.74M 0.04%
60,323
+3,190
+6% +$199K

Similar funds

Segall Bryant & Hamill's Q2 2026 Portfolio in Review

As of Q2 2026, Segall Bryant & Hamill held 678 positions worth $8.43B, up 21% from $6.98B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Segall Bryant & Hamill's Q2 2026 filing shows 102 new, 209 increased, 234 reduced and 88 closed positions. Its largest new stake was Marathon Digital Holdings: 2,756,177 shares worth $38.3M. The largest sale was Onto Innovation, an estimated $45.9M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Industrials and Financials.

  • Segall Bryant & Hamill's largest Q2 2026 buy was Marathon Digital Holdings: 2,756,177 shares worth $38.3M.
  • Segall Bryant & Hamill added most to Timken Company in Q2 2026, an estimated $45.3M increase.
  • Segall Bryant & Hamill's biggest Q2 2026 reduction was Onto Innovation, cutting an estimated $45.9M.
  • Segall Bryant & Hamill fully exited Axcelis in Q2 2026, selling an estimated $18.7M.
  • Segall Bryant & Hamill's ten largest holdings make up 13% of its $8.43B portfolio in Q2 2026.
  • Segall Bryant & Hamill opened 102 new positions and closed 88 in Q2 2026.
  • Segall Bryant & Hamill's portfolio value rose 21% quarter-over-quarter to $8.43B.

Based on Segall Bryant & Hamill's 13F filing for Q2 2026, filed 12 Aug 2026.